Clinithink Wins Two AIconics 2019 Awards in San Francisco

SAN FRANCISCO, Oct. 1, 2019 /PRNewswire/ — Clinithink’s CLiX AI solution won two prestigious awards at the AIconics 2019 Awards held on 24 September in the Golden Ballroom of the Palace Hotel in San Francisco. Clinithink was presented with their winners’ trophies in two categories: ‘Best Application of AI in Healthcare’ and ‘Best Innovation in NLP’ (Natural Language Processing).

The world renowned AIconics Awards take place as the annual AI Summit commences, and they celebrate the best in artificial intelligence worldwide – recognising the outstanding achievements derived from harnessing breakthrough innovation.

For their award entries Clinithink outlined how CLiX delivers the deepest, fastest and most accurate analysis of unstructured patient data currently possible thanks to their ground-breaking clinical natural language processing ability. This enriched insight into the real narrative of the patient story within the electronic medical record opens up an entirely new healthcare landscape. By informing treatment decisions, diagnosing rare disease, by finding many more potential candidates (in less time) for clinical trials, and by protecting healthcare spending through reducing claims denials and avoidance, CLiX AI is changing patient care for everyone, both now and into the future.

CLiX is AI that is changing rare disease diagnosis to save lives.

In a collaboration with Rady Children’s Institute for Genomic Medicine (RCIGM) CLiX helped diagnose rare genetic disease in a world record breaking 19 hours. Thanks to this study our AI is now opening the door to the increased use of genome sequencing as a first-line diagnostic test for babies with rare genetic disorders. Dr Stephen Kingsmore, President and CEO of RCIGM: “Some people call this artificial intelligence, we call it augmented intelligence.”

CLiX is AI that is improving every patient’s access to potentially life changing clinical trials.

Newcastle upon Tyne Hospitals NHS Foundation Trust (NUTH) spent three years manually reviewing the medical records of over 2000 patients to identify just 30 potentially eligible candidates for a clinical trial. With CLiX ENRICH on board, NUTH were able to process the electronic medical records of 270,000 patients in less than 24 hours, providing a shortlist of 100 potentially eligible patients. Professor Yan Yiannakou, Director of the Phase III Unit for NUTH: “This is a genuinely intelligent system which is not dependent on coding – it actually reads the health record, producing eligibility lists which are always accurate.”

Dr Chris Tackaberry, CEO of Clinithink, said of the win: “It was just as well we had both Glenn Keet and Nathan Skorick attending the AIconics as it was incredible to receive two awards. We are immensely proud as we feel these awards just reiterate how our AI solutions are making a huge difference in the real world and driving an evolution in the development of healthcare services across the globe.”

The full list of AIconics 2019 winners can be found at
https://aibusiness.com/AIconics-awards-san-francisco-2019-winners-announced/

About Clinithink 
Clinithink’s platform delivers the deepest, fastest and most accurate analysis of unstructured data across patient populations currently possible. This analysis provides medical professionals with the knowledge they need to quickly and accurately diagnose conditions and plan the most effective treatments. It enables our healthcare partners to provide optimal care to patients that is swiftly reimbursed, protecting their ability to deliver care to the people who need it most.  And it can also fast forward drug development; ensuring protocols are optimized, patients matched and sites identified in a fraction of the time of manual processing – helping our life science associates get the treatments patients need to market faster. For further information visit clinithink.com

NOTES TO EDITORS:
For more information contact marketing@clinithink.com

ABOUT THE AICONICS AWARDS:
Beginning in 2016, The AIconics provides innovators from around the globe with the platform to showcase themselves to their peers as well as millions of enterprise end-users. These prestigious global Awards create the ultimate showcase for the best and brightest people, projects and transformational innovations. With many new and exciting award categories now open for entries globally, the AIconics acknowledges the advances in technologies and disciplines being made, as we explore and push at the very definition of what can be accomplished by AI.

Contact:
Nicki Grace
02921250190
223900@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/clinithink-wins-two-aiconics-2019-awards-in-san-francisco-300928519.html

SOURCE Clinithink

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

8 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

9 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

9 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

10 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

12 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

12 hours ago